The authors assert that topiramate is an effective antiobesity medication in obese patients with diabetes, and also improves patients' glycemic control; however, these results require confirmation.

In the longterm, these findings have the potential to help develop novel gut microbiota-based therapies to normalize pancreas function in obese diabetes patients. “Our results are quite novel and very ...

Can walking speed reveal health risks in obesity? Yes, a quicker pace reduces the chances of diabetes, hypertension, and more ...

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The cutting-edge weight-loss drug Zepbound can protect obese people from ...

When it comes to lowering your risk of diabetes, there are a lot of things within your control, like cutting down on sugary ...

Such research is leading to new ways of thinking about how to combat type 2 diabetes. Bariatric surgery has been used for more than half a century to promote weight loss in severely obese ...

Research published this week reveals surprising information about potentially lowering your risk of the chronic condition.

This reflects an increase in associated risk factors such as being overweight or obese. Over the past decade, diabetes prevalence has risen faster in low and middle-income countries than in high ...

The study found being overweight but not obese during pregnancy also increases the diabetes risk by almost half Babies born to mothers who were obese during pregnancy are three times more likely ...

WEDNESDAY, Nov. 27, 2024 (HealthDay News) -- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found. Zepbound reduced ...

The new results show that after 176 weeks of treatment, only 1.3% of patients who were both obese and prediabetic, and who took the drug in any of three doses, progressed to type 2 diabetes ...